Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDR1 | Q08345 | 3/20 | 0.36 |
| ▸ | USP1 | O94782 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.31 |
| ▸ | F10 | P00742 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | SDHB | P21912 | 1/20 | 0.30 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.30 |
| ▸ | FEN1 | P39748 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20104431 | 0.86 | DDR1 (0.34) | DDR1PTGS2 | |
| SCHEMBL31248460 | 0.85 | XPO1 (0.32) | — | |
| SCHEMBL23005340 | 0.85 | XPO1 (0.32) | — | |
| SCHEMBL23005344 | 0.84 | DDR1 (0.32) | DDR1 | |
| SCHEMBL31248463 | 0.84 | DDR1 (0.32) | DDR1 | |
| SCHEMBL31248466 | 0.84 | DDR1 (0.33) | DDR1 | |
| SCHEMBL20104477 | 0.84 | DDR1 (0.33) | DDR1 | |
| SCHEMBL20104440 | 0.82 | DDR1 (0.30) | DDR1 | |
| SCHEMBL20104475 | 0.82 | DDR1 (0.33) | DDR1 | |
| SCHEMBL31248458 | 0.82 | DDR1 (0.30) | DDR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12152024-B2 | Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents | SYNGENTA CROP PROTECTION AG (CH) | 2024-11-26 | — | — | US | disclosed |
| EP-3532471-B1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG (CH) | 2021-09-15 | — | — | EP | disclosed |
| EP-3532471-B1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG (CH) | 2021-09-15 | — | — | EP | disclosed |
| US-20210053970-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG (CH) | 2021-02-25 | — | — | US | disclosed |
| US-10889583-B2 | Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents | SYNGENTA PARTICIPATIONS AG (CH) | 2021-01-12 | — | — | US | disclosed |
| US-10889583-B2 | Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents | SYNGENTA PARTICIPATIONS AG (CH) | 2021-01-12 | — | — | US | disclosed |
| US-20190352299-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG (CH) | 2019-11-21 | — | — | US | disclosed |
| US-20190352299-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG (CH) | 2019-11-21 | — | — | US | disclosed |
| WO-2018077565-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | SYNGENTA PARTICIPATIONS AG (CH) | 2018-05-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210053970-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | DDT, SHMT1, ACHE | DDR1 4387/4885USP1 1298/4885PDE2A 939/4885 |
| US-10889583-B2 | Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents | DDT, ACHE, PNMT | DDR1 4413/4885USP1 1528/4885PDE2A 699/4885 |
| US-12152024-B2 | Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents | DDT, SHMT1, ACHE | DDR1 4387/4885USP1 1298/4885PDE2A 939/4885 |
| US-20190352299-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR AND HYDROXYLAMINE SUBSTITUENTS | DDT, ACHE, PNMT | DDR1 4413/4885USP1 1528/4885PDE2A 699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.